Overview
The goal of this clinical trial is to compare in acne vulgaris patients. The main question it aims to answer is:
• To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment, following a 2-month treatment regimen that includes vitamin D supplementation compared to conventional (systemic azithromycin and topical retinoid) treatment alone.
Participants will receive vitamin D supplements in addition to capsule Azithromycin and topical retinoid.
Researchers will compare groups to determine efficacy of Vitamin D supplements in the treatment of Acne vulgaris.
Eligibility
Inclusion Criteria:
- Individuals aged between 13 and 40 years with diagnoses of Acne vulgaris are included.
Exclusion Criteria:
- Individuals currently undergoing treatment for polycystic ovary syndrome (PCOs)
- Those with obesity
- Individuals employing vitamin supplementation
- Those under the influence of topical or systemic steroids and acne treatment in the last 2 months.